SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-22-042031
Filing Date
2022-02-14
Accepted
2022-02-14 16:52:54
Documents
3
Group Members
KEVIN P. STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP III, L.P.THIRD ROCK VENTURES GP IV, L.P.THIRD ROCK VENTURES IV, L.P.TRV GP III, LLCTRV GP IV, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d275867dsc13ga.htm SC 13G/A 175096
2 EXHIBIT 24 d275867dex9924.htm EX-99.24 4255
3 EX-99.1 d275867dex991.htm EX-99.1 11778
  Complete submission text file 0001193125-22-042031.txt   192935
Mailing Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures III, L.P. (Filed by) CIK: 0001569705 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Subject) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92097 | Film No.: 22633894
SIC: 2836 Biological Products, (No Diagnostic Substances)